RNA Therapy for Genetic Laminopathies

About Phlox Therapeutics

Phlox Therapeutics is an early-stage biotech focused on developing innovative RNA therapies for genetic cardiomyopathies, particularly laminopathies. The company has secured seed funding to advance its lead program into preclinical development and has entered a strategic research collaboration with Solid Biosciences. With a founding team of renowned cardiac research experts, Phlox is positioned to address a significant unmet medical need in a major global disease area.

Therapeutic Areas